AstraZeneca’s chronic obstructive pulmonary disease (COPD) candidate has served up a third phase 3 win this year, offering ...

Positive high-level results from the pivotal Phase III MIRANDA trial showed potential first-in-class tozorakimab demonstrated a statistically significant and clinically meaningful reduction in the ...

Respiratory medicine has increasingly recognized the critical influence of respiratory viral infections on the development and exacerbation of chronic ...

The Current Air Quality Crisis The state of air quality today is alarming, affecting not just major cities but also smaller towns. Many individuals are now suffering from respiratory issues such as ...

AeroDel’s founders, Zahir Jaffer, Shradha Sangwai and K.K.Suraj Rajan, have one common denominator: asthma. This led them to ...

Here’s our weekly round-up of what illnesses are spreading the most in Metro Detroit communities, according to our local ...

COPD without smoking? New data reveal unexpected symptoms and inflammation patterns. Read more to see what this means for ...

We are surrounded by hundreds of products that are deleterious to our health, including foods, beverages, aerosols, and ...

KT-621 BREADTH Phase 2b asthma trial ongoing, with data expected to be reported in late 2027KT-621 BROADEN2 Phase 2b atopic dermatitis (AD) trial ...

Patients with respiratory conditions, such as asthma and COPD, are being encouraged to use apps to manage their symptoms. Featuring videos on how to us inhalers correctly and learn breathing ...

Health experts have called for immediate, coordinated measures to tackle the growing prevalence of asthma and Chronic Obstructive Pulmonary Disease (COPD) in Nigeria, citing poor awareness, weak ...